MENU

YMAB Y-mAbs Therapeutics Forecast, Technical & Fundamental Analysis

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology
YMAB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
YMAB
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

YMAB is expected to report earnings to fall 29.00% to -14 cents per share on November 08

Y-mAbs Therapeutics YMAB Stock Earnings Reports
Q3'24
Est.
$-0.15
Q2'24
Missed
by $0.09
Q1'24
Missed
by $0.01
Q4'23
Beat
by $0.18
Q3'23
Beat
by $0.01
The last earnings report on August 12 showed earnings per share of -20 cents, missing the estimate of -11 cents. With 75.64K shares outstanding, the current market capitalization sits at 662.75M.
A.I. Advisor
published General Information

General Information

a developer of novel antibody therapeutics for oncology targets

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
230 Park Avenue
Phone
+1 646 885-8505
Employees
100
Web
https://www.ymabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLIFX35.830.10
+0.28%
Value Line Mid Cap Focused
DEVDX12.88N/A
N/A
Driehaus Event Driven
HWAIX41.15-0.01
-0.02%
Hotchkis & Wiley Value Opps Instl
NBPIX46.88-0.15
-0.32%
Neuberger Berman Large Cap Value Instl
HIOIX12.15-0.05
-0.41%
Fintrust Income and Opportunity Instl

YMAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, YMAB has been loosely correlated with RCKT. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if YMAB jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YMAB
1D Price
Change %
YMAB100%
+0.88%
RCKT - YMAB
38%
Loosely correlated
-0.91%
IDYA - YMAB
38%
Loosely correlated
+4.90%
PGEN - YMAB
36%
Loosely correlated
-0.49%
FATE - YMAB
36%
Loosely correlated
+13.58%
NKTX - YMAB
35%
Loosely correlated
+1.25%
More